UPC Analytics
ENDE
Overview · Filed: Oct 28, 2024

UPC_CFI_628/2024

EMBOLIC PROTECTION DEVICE

InfringementMain Infringement ActionMunich LDInfringementCase Closed
Parties

Claimants

  • Emboline, Inc.
Reps: Thure Schubert (Vossius & Brinkhof UPC Litigators)

Respondents

  • AorticLab srl
Reps: Sabine Agé (HOYNG ROKH MONEGIER)
Judges
  • Matthias Zigann
  • Tobias Pichlmaier
  • Petri Rinkinen
  • Elisabetta Papa
Patents
  • EP2129425
  • EP 2 129 425
CPC codes: A61F2230/0065, A61F2230/0006, A61F2250/0023, A61F2250/0003, A61F2/0105, A61F2002/018, A61F2250/0069, A61F2230/0067, A61F2230/0069, A61F2/011

Technology area: Medical Devices · Implants

Sector: Pharmaceutical & Medical

Outcome
Not infringedNot infringed
Filed: Oct 28, 2024
First decided: Jan 13, 2026
Language: English

Final decision on the merits in infringement action by Emboline, Inc. against AorticLab srl (EP 2 129 425, medical device). Court dismissed the infringement action finding the patent not infringed. The defendant's counterclaim for revocation was conditional (dependent on a finding of infringement), and since no infringement was found, no decision was made on the counterclaim. Both parties bear their own costs. Key headnotes: infringement not excluded by normal non-infringing operation if patent-compliant use remains possible; irregular use of a medical device in line with professional practice can constitute infringement; conditional counterclaim limited in scope (Rule 263.3 RoP).

Open on UPC Registry
Claims
At issueall
Not infringedall
Notes: Infringement action dismissed for EP 2 129 425; conditional counterclaim for revocation not decided as condition (infringement finding) not met.